{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:31:38Z","timestamp":1792701098056,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009620","name":"Science and Technology Department of Gansu Province","doi-asserted-by":"publisher","award":["23JRRA1487"],"award-info":[{"award-number":["23JRRA1487"]}],"id":[{"id":"10.13039\/501100009620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009620","name":"Science and Technology Department of Gansu Province","doi-asserted-by":"publisher","award":["23JRRA1487"],"award-info":[{"award-number":["23JRRA1487"]}],"id":[{"id":"10.13039\/501100009620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009620","name":"Science and Technology Department of Gansu Province","doi-asserted-by":"publisher","award":["23JRRA1487"],"award-info":[{"award-number":["23JRRA1487"]}],"id":[{"id":"10.13039\/501100009620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009620","name":"Science and Technology Department of Gansu Province","doi-asserted-by":"publisher","award":["23JRRA1487"],"award-info":[{"award-number":["23JRRA1487"]}],"id":[{"id":"10.13039\/501100009620","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-80801-8","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T22:32:01Z","timestamp":1733437921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Predictive role of neutrophil percentage-to-albumin ratio, neutrophil-to-lymphocyte ratio, and systemic immune-inflammation index for mortality in patients with MASLD"],"prefix":"10.1038","volume":"14","author":[{"given":"Kaixuan","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"issue":"9","key":"80801_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi, K. et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 7(9), 851\u2013861 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"2","key":"80801_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi, H. et al. Global burden of liver disease: 2023 update. J. Hepatol. 79(2), 516\u2013537 (2023).","journal-title":"J. Hepatol."},{"issue":"7","key":"80801_CR3","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam, M., Sanyal, A. J. & George, J. MAFLD: A Consensus-Driven proposed nomenclature for metabolic Associated fatty liver disease. Gastroenterology 158(7), 1999\u20132014 (2020). e1991.","journal-title":"Gastroenterology"},{"issue":"1","key":"80801_CR4","doi-asserted-by":"publisher","first-page":"101133","DOI":"10.1016\/j.aohep.2023.101133","volume":"29","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Ann. Hepatol. 29(1), 101133 (2023).","journal-title":"Ann. Hepatol."},{"issue":"3","key":"80801_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7570\/jomes23052","volume":"32","author":"WK Chan","year":"2023","unstructured":"Chan, W. K. et al. Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD): a state-of-the-art review. J. Obes. Metabolic Syndrome 32(3), 197\u2013213 (2023).","journal-title":"J. Obes. Metabolic Syndrome"},{"issue":"6","key":"80801_CR6","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.1016\/S1470-2045(22)00265-0","volume":"23","author":"DJH Tan","year":"2022","unstructured":"Tan, D. J. H., Ng, C. H., Muthiah, M. D., Loomba, R. & Huang, D. Q. Clinical features and outcomes of NAFLD-related hepatocellular carcinoma - authors\u2019 reply. Lancet Oncol. 23(6), e244 (2022).","journal-title":"Lancet Oncol."},{"issue":"9","key":"80801_CR7","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","volume":"69","author":"G Targher","year":"2020","unstructured":"Targher, G., Byrne, C. D. & Tilg, H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut 69(9), 1691\u20131705 (2020).","journal-title":"Gut"},{"issue":"6","key":"80801_CR8","doi-asserted-by":"publisher","first-page":"949","DOI":"10.21037\/hbsn-23-542","volume":"12","author":"J Bilson","year":"2023","unstructured":"Bilson, J. & Byrne, C. D. Fatty liver disease and risk of all cause and cause-specific mortality outcomes in the older population. Hepatobiliary Surg. Nutr. 12(6), 949\u2013952 (2023).","journal-title":"Hepatobiliary Surg. Nutr."},{"issue":"4","key":"80801_CR9","doi-asserted-by":"publisher","first-page":"579","DOI":"10.14309\/ajg.0000000000000058","volume":"114","author":"A Cheung","year":"2019","unstructured":"Cheung, A., Figueredo, C. & Rinella, M. E. Nonalcoholic fatty liver disease: identification and management of high-risk patients. Am. J. Gastroenterol. 114(4), 579\u2013590 (2019).","journal-title":"Am. J. Gastroenterol."},{"issue":"11","key":"80801_CR10","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s00018-023-04966-7","volume":"80","author":"RI Velliou","year":"2023","unstructured":"Velliou, R. I., Legaki, A. I., Nikolakopoulou, P., Vlachogiannis, N. I. & Chatzigeorgiou, A. Liver endothelial cells in NAFLD and transition to NASH and HCC. Cell. Mol. Life Sci. 80(11), 314 (2023).","journal-title":"Cell. Mol. Life Sci."},{"key":"80801_CR11","doi-asserted-by":"crossref","unstructured":"Motta, B. M., Masarone, M., Torre, P. & Persico, M. From Non-alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): epidemiology, incidence, predictions, risk factors, and Prevention. Cancers 15(22). (2023).","DOI":"10.3390\/cancers15225458"},{"key":"80801_CR12","doi-asserted-by":"crossref","unstructured":"Lekakis, V. & Papatheodoridis, G. V. Natural history of metabolic dysfunction-associated steatotic liver disease. Eur. J. Intern. Med. (2023).","DOI":"10.1016\/j.ejim.2023.11.005"},{"key":"80801_CR13","doi-asserted-by":"publisher","first-page":"149369","DOI":"10.1016\/j.bbrc.2023.149369","volume":"693","author":"M Imamori","year":"2023","unstructured":"Imamori, M. et al. Thrombospondin-1 promotes liver fibrosis by enhancing TGF-\u03b2 action in hepatic stellate cells. Biochem. Biophys. Res. Commun. 693, 149369 (2023).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"80801_CR14","doi-asserted-by":"publisher","first-page":"2285924","DOI":"10.1080\/07853890.2023.2285924","volume":"55","author":"TT Chen","year":"2023","unstructured":"Chen, T. T. et al. Prediction value of neutrophil and eosinophil count at risk of COPD exacerbation. Ann. Med. 55(2), 2285924 (2023).","journal-title":"Ann. Med."},{"issue":"1","key":"80801_CR15","doi-asserted-by":"publisher","first-page":"e24136","DOI":"10.1002\/jcla.24136","volume":"36","author":"K Dai","year":"2022","unstructured":"Dai, K. et al. Neutrophil percentage-to-albumin ratio and monocyte-to-lymphocyte ratio as predictors of free-wall rupture in patients with acute myocardial infarction. J. Clin. Lab. Anal. 36(1), e24136 (2022).","journal-title":"J. Clin. Lab. Anal."},{"issue":"23","key":"80801_CR16","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","volume":"20","author":"B Hu","year":"2014","unstructured":"Hu, B. et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin. cancer Research: Official J. Am. Association Cancer Res. 20(23), 6212\u20136222 (2014).","journal-title":"Clin. cancer Research: Official J. Am. Association Cancer Res."},{"issue":"6","key":"80801_CR17","first-page":"565","volume":"43","author":"\u00c7 \u00d6 \u0131rako\u011flu","year":"2021","unstructured":"\u00d6 \u0131rako\u011flu, \u00c7. & AS Y\u0131lmaz, F. Systemic immune-inflammation index is associated with increased carotid intima-media thickness in hypertensive patients. Clin. Experimental Hypertens. (New York NY: 1993). 43(6), 565\u2013571 (2021).","journal-title":"Clin. Experimental Hypertens. (New York NY: 1993)"},{"key":"80801_CR18","unstructured":"Curtin, L. R. et al. National Health and Nutrition Examination Survey: sample design, 2007\u20132010. Vital Health Stat. Ser. 2 Data Evaluation Methods Res. 2013(160):1\u201323 ."},{"issue":"1","key":"80801_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/apt.13012","volume":"41","author":"CE Ruhl","year":"2015","unstructured":"Ruhl, C. E. & Everhart, J. E. Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey. Aliment. Pharmacol. Ther. 41(1), 65\u201376 (2015).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"80801_CR20","doi-asserted-by":"crossref","unstructured":"Song, S. J., Lai, J. C., Wong, G. L., Wong, V. W. & Yip, T. C. Can we use old NAFLD data under the new MASLD definition? J. Hepatol. (2023).","DOI":"10.1016\/j.jhep.2023.07.021"},{"issue":"1","key":"80801_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S2213-8587(18)30316-4","volume":"7","author":"X Zou","year":"2019","unstructured":"Zou, X., Zhou, X., Zhu, Z. & Ji, L. Novel subgroups of patients with adult-onset diabetes in Chinese and US populations. Lancet Diabetes Endocrinol. 7(1), 9\u201311 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"9","key":"80801_CR22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150(9), 604\u2013612 (2009).","journal-title":"Ann. Intern. Med."},{"key":"80801_CR23","doi-asserted-by":"publisher","first-page":"101805","DOI":"10.1016\/j.pupt.2019.101805","volume":"58","author":"B Ibrahimou","year":"2019","unstructured":"Ibrahimou, B., Azim, S. I. & Sun, N. Interaction between blood lead level and chronic obstructive pulmonary disease (COPD) on risk of heart attack or stroke: USA NHANES, 2013\u20132014. Pulm. Pharmacol. Ther. 58, 101805 (2019).","journal-title":"Pulm. Pharmacol. Ther."},{"key":"80801_CR24","doi-asserted-by":"crossref","unstructured":"Mellemkj\u00e6r, A., Kj\u00e6r, M. B., Haldrup, D., Gr\u00f8nb\u00e6k, H. & Thomsen, K. L. Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease. Eur. J. Intern. Med. (2023).","DOI":"10.1016\/j.ejim.2023.11.012"},{"issue":"4","key":"80801_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1089\/met.2019.0115","volume":"18","author":"K Lechner","year":"2020","unstructured":"Lechner, K. et al. High-risk atherosclerosis and metabolic phenotype: the roles of ectopic adiposity, Atherogenic Dyslipidemia, and inflammation. Metab. Syndr. Relat. Disord. 18(4), 176\u2013185 (2020).","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"6","key":"80801_CR26","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.amjmed.2019.10.031","volume":"133","author":"A Eckart","year":"2020","unstructured":"Eckart, A. et al. Relationship of nutritional status, inflammation, and serum albumin levels during Acute illness: a prospective study. Am. J. Med. 133(6), 713\u2013722e717 (2020).","journal-title":"Am. J. Med."},{"issue":"1","key":"80801_CR27","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1186\/s12872-021-02431-6","volume":"21","author":"H Huang","year":"2021","unstructured":"Huang, H. et al. Independent and joint effects of high-sensitivity c-reactive protein and hypoalbuminemia on long-term all-cause mortality among coronary artery disease: a prospective and multicenter cohort study. BMC Cardiovasc. Disord. 21(1), 613 (2021).","journal-title":"BMC Cardiovasc. Disord."},{"issue":"5","key":"80801_CR28","doi-asserted-by":"publisher","first-page":"e0217006","DOI":"10.1371\/journal.pone.0217006","volume":"14","author":"T J\u00e4ntti","year":"2019","unstructured":"J\u00e4ntti, T. et al. Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shock. PloS One 14(5), e0217006 (2019).","journal-title":"PloS One"},{"issue":"1","key":"80801_CR29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s12072-015-9665-6","volume":"10","author":"R Spinella","year":"2016","unstructured":"Spinella, R., Sawhney, R. & Jalan, R. Albumin in chronic liver disease: structure, functions and therapeutic implications. Hep. Intl. 10(1), 124\u2013132 (2016).","journal-title":"Hep. Intl."},{"issue":"6","key":"80801_CR30","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.27322","volume":"60","author":"M Domenicali","year":"2014","unstructured":"Domenicali, M. et al. Posttranscriptional changes of serum albumin: clinical and prognostic significance in hospitalized patients with cirrhosis. Hepatol. (Baltimore Md) 60(6), 1851\u20131860 (2014).","journal-title":"Hepatol. (Baltimore Md)"},{"key":"80801_CR31","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1017\/S0950268820000771","volume":"148","author":"Y Gong","year":"2020","unstructured":"Gong, Y., Li, D., Cheng, B., Ying, B. & Wang, B. Increased neutrophil percentage-to-albumin ratio is associated with all-cause mortality in patients with severe sepsis or septic shock. Epidemiol. Infect. 148, e87 (2020).","journal-title":"Epidemiol. Infect."},{"key":"80801_CR32","doi-asserted-by":"crossref","unstructured":"Sun, T. et al. Association between Neutrophil Percentage-to-Albumin Ratio and All-Cause Mortality in Critically Ill Patients with Coronary Artery Disease. BioMed research international 2020:8137576. (2020).","DOI":"10.1155\/2020\/8137576"},{"key":"80801_CR33","doi-asserted-by":"crossref","unstructured":"Yu, Y. et al. The Neutrophil Percentage-to-Albumin Ratio as a New Predictor of All-Cause Mortality in Patients with Cardiogenic Shock. BioMed research international 2020:7458451. (2020).","DOI":"10.1155\/2020\/7458451"},{"issue":"2","key":"80801_CR34","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/MEG.0000000000002470","volume":"35","author":"X Du","year":"2023","unstructured":"Du, X. et al. Higher levels of neutrophil percentage-to-albumin ratio predict increased mortality risk in patients with liver cirrhosis: a retrospective cohort study. Eur. J. Gastroenterol. Hepatol. 35(2), 198\u2013203 (2023).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"12","key":"80801_CR35","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/resp.14589","volume":"28","author":"CC Lan","year":"2023","unstructured":"Lan, C. C., Su, W. L., Yang, M. C., Chen, S. Y. & Wu, Y. K. Predictive role of neutrophil-percentage-to-albumin, neutrophil-to-lymphocyte and eosinophil-to-lymphocyte ratios for mortality in patients with COPD: evidence from NHANES 2011\u20132018. Respirol. (Carlton Vic) 28(12), 1136\u20131146 (2023).","journal-title":"Respirol. (Carlton Vic)"},{"issue":"1","key":"80801_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1586\/erc.12.159","volume":"11","author":"T Bhat","year":"2013","unstructured":"Bhat, T. et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev. Cardiovasc. Ther. 11(1), 55\u201359 (2013).","journal-title":"Expert Rev. Cardiovasc. Ther."},{"issue":"1","key":"80801_CR37","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/MEG.0000000000000486","volume":"28","author":"A Abdel-Razik","year":"2016","unstructured":"Abdel-Razik, A. et al. A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: multicentric study. Eur. J. Gastroenterol. Hepatol. 28(1), e1\u20139 (2016).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"3","key":"80801_CR38","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1002\/cam4.5185","volume":"12","author":"CE Thomas","year":"2023","unstructured":"Thomas, C. E. et al. Neutrophil-lymphocyte ratio in relation to risk of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. Cancer Med. 12(3), 3589\u20133600 (2023).","journal-title":"Cancer Med."},{"issue":"4","key":"80801_CR39","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.diabet.2015.01.001","volume":"41","author":"M Verdoia","year":"2015","unstructured":"Verdoia, M. et al. Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease. Diabetes Metab. 41(4), 304\u2013311 (2015).","journal-title":"Diabetes Metab."},{"issue":"1","key":"80801_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12933-021-01324-4","volume":"20","author":"CRL Cardoso","year":"2021","unstructured":"Cardoso, C. R. L., Leite, N. C. & Salles, G. F. Importance of hematological parameters for micro- and macrovascular outcomes in patients with type 2 diabetes: the Rio De Janeiro type 2 diabetes cohort study. Cardiovasc. Diabetol. 20(1), 133 (2021).","journal-title":"Cardiovasc. Diabetol."},{"issue":"8029","key":"80801_CR41","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41586-024-07820-3","volume":"633","author":"M Malamud","year":"2024","unstructured":"Malamud, M. et al. Recognition and control of neutrophil extracellular trap formation by MICL. Nature 633(8029), 442\u2013450 (2024).","journal-title":"Nature"},{"issue":"6","key":"80801_CR42","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1042\/BST20190629","volume":"47","author":"M Euler","year":"2019","unstructured":"Euler, M. & Hoffmann, M. H. The double-edged role of neutrophil extracellular traps in inflammation. Biochem. Soc. Trans. 47(6), 1921\u20131930 (2019).","journal-title":"Biochem. Soc. Trans."},{"issue":"20","key":"80801_CR43","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1128\/MCB.00518-15","volume":"35","author":"S Fabbiano","year":"2015","unstructured":"Fabbiano, S. et al. Immunosuppression-Independent Role of Regulatory T Cells against hypertension-driven renal dysfunctions. Mol. Cell. Biol. 35(20), 3528\u20133546 (2015).","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"80801_CR44","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/oxfordjournals.eurheartj.a060880","volume":"16","author":"T Siminiak","year":"1995","unstructured":"Siminiak, T., Flores, N. A. & Sheridan, D. J. Neutrophil interactions with endothelium and platelets: possible role in the development of cardiovascular injury. Eur. Heart J. 16(2), 160\u2013170 (1995).","journal-title":"Eur. Heart J."},{"issue":"11","key":"80801_CR45","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1097\/HJH.0000000000003250","volume":"40","author":"J Li","year":"2022","unstructured":"Li, J. et al. Inflammatory cytokines induce neutrophil extracellular traps interaction with activated platelets and endothelial cells exacerbate coagulation in moderate and severe essential hypertension. J. Hypertens. 40(11), 2219\u20132229 (2022).","journal-title":"J. Hypertens."},{"key":"80801_CR46","doi-asserted-by":"crossref","unstructured":"Chrysanthopoulou, A. et al. Angiotensin II triggers release of neutrophil extracellular traps, linking thromboinflammation with essential hypertension. JCI insight 6(18). (2021).","DOI":"10.1172\/jci.insight.148668"},{"key":"80801_CR47","doi-asserted-by":"crossref","unstructured":"Yaghmaei, H. et al. The Role of Gut Microbiota Modification in Nonalcoholic Fatty Liver Disease Treatment Strategies. International journal of hepatology 2024:4183880. (2024).","DOI":"10.1155\/2024\/4183880"},{"key":"80801_CR48","doi-asserted-by":"crossref","unstructured":"Pavlovic, N., Rani, B., Gerwins, P. & Heindryckx, F. Platelets as key factors in Hepatocellular Carcinoma. Cancers 11(7). (2019).","DOI":"10.3390\/cancers11071022"},{"issue":"4","key":"80801_CR49","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1002\/hep.23435","volume":"51","author":"MM Zaldivar","year":"2010","unstructured":"Zaldivar, M. M. et al. CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis. Hepatol. (Baltimore Md) 51(4), 1345\u20131353 (2010).","journal-title":"Hepatol. (Baltimore Md)"},{"issue":"6","key":"80801_CR50","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1053\/j.gastro.2014.08.038","volume":"147","author":"S Yoshida","year":"2014","unstructured":"Yoshida, S. et al. Extrahepatic platelet-derived growth factor-\u03b2, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice. Gastroenterology 147(6), 1378\u20131392 (2014).","journal-title":"Gastroenterology"},{"issue":"3","key":"80801_CR51","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00432-022-03925-2","volume":"149","author":"YY Liu","year":"2023","unstructured":"Liu, Y. Y. et al. Systemic inflammation with Sarcopenia predicts survival in patients with gastric cancer. J. Cancer Res. Clin. Oncol. 149(3), 1249\u20131259 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"80801_CR52","doi-asserted-by":"publisher","first-page":"829689","DOI":"10.3389\/fonc.2022.829689","volume":"12","author":"K He","year":"2022","unstructured":"He, K. et al. Preoperative systemic Immune-inflammation index (SII) as a Superior Predictor of Long-Term Survival Outcome in patients with stage I-II gastric Cancer after radical surgery. Front. Oncol. 12, 829689 (2022).","journal-title":"Front. Oncol."},{"issue":"7","key":"80801_CR53","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s40520-022-02103-1","volume":"34","author":"AL Orhan","year":"2022","unstructured":"Orhan, A. L. et al. Evaluating the systemic immune-inflammation index for in-hospital and long-term mortality in elderly non-ST-elevation myocardial infarction patients. Aging Clin. Exp. Res. 34(7), 1687\u20131695 (2022).","journal-title":"Aging Clin. Exp. Res."},{"key":"80801_CR54","doi-asserted-by":"publisher","first-page":"933913","DOI":"10.3389\/fcvm.2022.933913","volume":"9","author":"Z Ye","year":"2022","unstructured":"Ye, Z. et al. Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: a systematic review and meta-analysis. Front. Cardiovasc. Med. 9, 933913 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"80801_CR55","doi-asserted-by":"crossref","unstructured":"Ren, A. et al. Systemic Immune-Inflammation Index Is a Prognostic Predictor in Patients with Intrahepatic Cholangiocarcinoma Undergoing Liver Transplantation. Mediators of inflammation 2021:6656996. (2021).","DOI":"10.1155\/2021\/6656996"},{"key":"80801_CR56","doi-asserted-by":"publisher","first-page":"925690","DOI":"10.3389\/fimmu.2022.925690","volume":"13","author":"R Xie","year":"2022","unstructured":"Xie, R. et al. Association between SII and hepatic steatosis and liver fibrosis: a population-based study. Front. Immunol. 13, 925690 (2022).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80801-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80801-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80801-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:07:23Z","timestamp":1733443643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80801-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["80801"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-80801-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The NHANES survey protocol was approved by the NCHS Ethics Review Committee, and all respondents signed an informed consent form so that secondary analyses of the data were conducted without the need for another ethical review. The approval of the NCHS Research Ethics Review Board can be accessed on the NHANES website () (accessed on June 4, 2024).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}}],"article-number":"30403"}}